104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
HB2584

 

Introduced 2/6/2025, by Rep. Kelly M. Cassidy

 

SYNOPSIS AS INTRODUCED:
 
215 ILCS 200/52 new
305 ILCS 5/5-54 new

    Amends the Prior Authorization Reform Act and the Illinois Public Aid Code. Provides that a health insurance issuer, the fee-for-service medical assistance program, and a Medicaid managed care organization may not require prior authorization for the following prescription drug types and their therapeutic equivalents approved by the United States Food and Drug Administration: human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis medication or human immunodeficiency virus treatment medication. Effective January 1, 2027.


LRB104 08321 BAB 18372 b

 

 

A BILL FOR

 

HB2584LRB104 08321 BAB 18372 b

1    AN ACT concerning regulation.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Prior Authorization Reform Act is amended
5by adding Section 52 as follows:
 
6    (215 ILCS 200/52 new)
7    Sec. 52. Prior authorization for certain prescription
8drugs; prohibited. A health insurance issuer may not require
9prior authorization for the following prescription drug types
10and their therapeutic equivalents approved by the United
11States Food and Drug Administration: human immunodeficiency
12virus pre-exposure prophylaxis and post-exposure prophylaxis
13medication or human immunodeficiency virus treatment
14medication.
 
15    Section 10. The Illinois Public Aid Code is amended by
16adding Section 5-54 as follows:
 
17    (305 ILCS 5/5-54 new)
18    Sec. 5-54. Prior authorization for certain prescription
19drugs; prohibited. The fee-for-service medical assistance
20program and a Medicaid managed care organization may not
21require prior authorization for the following prescription

 

 

HB2584- 2 -LRB104 08321 BAB 18372 b

1drug types and their therapeutic equivalents approved by the
2United States Food and Drug Administration: human
3immunodeficiency virus pre-exposure prophylaxis and
4post-exposure prophylaxis medication or human immunodeficiency
5virus treatment medication.
 
6    Section 99. Effective date. This Act takes effect January
71, 2027.